1. Home
  2. CARG vs SUPN Comparison

CARG vs SUPN Comparison

Compare CARG & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarGurus Inc.

CARG

CarGurus Inc.

HOLD

Current Price

$30.82

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$49.92

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARG
SUPN
Founded
2005
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
CARG
SUPN
Price
$30.82
$49.92
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$38.29
$61.60
AVG Volume (30 Days)
1.5M
720.1K
Earning Date
05-22-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
675.00
N/A
EPS
1.55
N/A
Revenue
$316,861,000.00
$392,755,000.00
Revenue This Year
$13.45
$23.19
Revenue Next Year
$8.75
$17.65
P/E Ratio
$19.97
N/A
Revenue Growth
59.92
N/A
52 Week Low
$24.65
$29.16
52 Week High
$39.42
$59.68

Technical Indicators

Market Signals
Indicator
CARG
SUPN
Relative Strength Index (RSI) 46.26 39.98
Support Level $28.80 $47.95
Resistance Level $35.55 $52.14
Average True Range (ATR) 1.21 2.40
MACD 0.14 -0.56
Stochastic Oscillator 43.61 0.85

Price Performance

Historical Comparison
CARG
SUPN

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: